Perspectives in molecular imaging using staging biomarkers and immunotherapies in Alzheimer's disease.
about
Molecular imaging as a guide for the treatment of central nervous system disordersEarly and Persistent O-GlcNAc Protein Modification in the Streptozotocin Model of Alzheimer's Disease.Cathepsin B Imaging to Predict Quality of Engineered Cartilage.Significance of normalization on anatomical MRI measures in predicting Alzheimer's disease
P2860
Perspectives in molecular imaging using staging biomarkers and immunotherapies in Alzheimer's disease.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Perspectives in molecular imag ...... rapies in Alzheimer's disease.
@en
Perspectives in molecular imag ...... rapies in Alzheimer's disease.
@nl
type
label
Perspectives in molecular imag ...... rapies in Alzheimer's disease.
@en
Perspectives in molecular imag ...... rapies in Alzheimer's disease.
@nl
prefLabel
Perspectives in molecular imag ...... rapies in Alzheimer's disease.
@en
Perspectives in molecular imag ...... rapies in Alzheimer's disease.
@nl
P2860
P356
P1476
Perspectives in molecular imag ...... rapies in Alzheimer's disease.
@en
P2093
Abedelnasser Abulrob
Benoît Leclerc
P2860
P304
P356
10.1155/2013/589308
P407
P5008
P577
2013-02-05T00:00:00Z